Farmasøytiske sammensetninger og anvendelse av disse i behandling av kreft
The invention provides a compound for use in a method for treating a solid tumor in a patient, wherein the compound is (+)-1,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and the method comprises administering the compound t...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Norwegian |
Published |
25.07.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides a compound for use in a method for treating a solid tumor in a patient, wherein the compound is (+)-1,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and the method comprises administering the compound to the patient in a dose of 10 mg/m 2 to 100 mg/m 2 . |
---|---|
Bibliography: | Application Number: NO20060004647 |